“A dynamic, strong and thriving biopharmaceutical sector is synonymous with health, well-being and prosperity,” the Regional Minister stated, noting that the region is home to 400 pharmaceutical companies, with a turnover of close to €5.1 billion, accounting for 26% of the national total.
“We are not talking about cold, isolated figures. Each of them represents an opportunity to continue improving treatments, therapies and research,” she concluded.